Research Disclosures & Disclaimers

This website contains disclosures and disclaimers related to
published UBS Global Research products, including those related to
regulation, potential conflicts of interest as well as those provided
by third-party data providers describing limitations on use of their
products.

CapitaLand Ascendas REIT (CAPD.SI)*

UBS Rating and Price Target History Chart

Line chart explaining Price target vs Stock Price is described in below table

EQ Rating & Price Target Table

Date Stock Price (S$) Price Target (S$) Rating
2022-02-282.773.22Neutral
2022-03-152.803.05Neutral
2022-07-142.863.02Neutral
2023-01-132.743.11Buy
2023-07-282.703.13Buy
2023-08-312.773.18Buy
2024-01-032.963.31Buy
2024-04-182.593.23Buy
2024-07-312.723.26Buy
2024-11-272.603.32Buy
2025-02-072.643.34Buy

Note : Historical Price Targets have been adjusted to account for any stock splits, rights issues and/or dividends which may have occurred for this security. Not Priced: Stock was not priced on the given date. No Rating: Issuer was not rated by UBS on the given day. No Price Target: For this issuer no Price Target was set by UBS on the given day. Issuers with an EQ Rating & Price Target Table are covered by UBS-IB Equity Research Analysts. Issuers without an EQ Rating & Price Target Table are not single stock covered.

* Issuers marked with an asterisk are covered by UBS-IB Equity Research Analysts. Issuers without an asterisk are not single stock covered.